Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study

Clinical Colorectal Cancer

Volumn 16, Issue 4, 2017, Pages 334-342

  Rho, Young Soo ^a   Gilabert, Marine ^b   Polom, Karol ^c   Aladashvili, Archil ^d   Kopeckova, Katerina ^e   Megdanova, Vera ^f   Coleman, Niamh ^g   Greally, Megan ^g   Marrelli, Daniele ^c   Roviello, Franco ^c   McDermott, Ray ^f   Petrova, Veneta ^f   Mihaylova, Zhasmina ^f   Bortlicek, Zbynek ^h   Prausova, Jana ^e   Batist, Gerald ^a,i   Azoulay, Laurent ^a,i,j   Kavan, Petr ^a,i  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUT PAOLI CALMETTES   (France)

^c UNIVERSITY OF SIENA   (Italy)

^d National Cancer Center of Georgia   (Georgia)

^e UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^f MILITARY MEDICAL ACADEMY   (Bulgaria)

^g ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^h MASARYK UNIVERSITY   (Czech Republic)

ⁱ MCGILL UNIVERSITY   (Canada)

^j MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Adolescent and young adults; Metastatic colorectal cancer; Real world; Treatment pattern; Young onset CRC

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB; REGORAFENIB;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; COLORECTAL CARCINOMA; COLORECTAL SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONSET AGE; PAIN; PROGRESSION FREE SURVIVAL; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; WEIGHT REDUCTION; ADENOCARCINOMA; AGED; CLINICAL TRIAL; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; INCIDENCE; INTERNATIONAL COOPERATION; METASTASIS; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BIOLOGICAL THERAPY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85018759080     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2017.03.008     Document Type: Article

References (39)

1. Ferlay, J., Soerjomataram, I., Ervik, M., et al. GLOBOCAN 2012. Available at: http://globocan.iarc.fr/ Accessed: May 7, 2016.
2. Center, M.M., Jemal, A., Smith, R.A., Ward, E., Worldwide variations in colorectal cancer. CA Cancer J Clin 59 (2009), 366–378.
3. Bailey, C.E., Hu, C.Y., You, Y.N., et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 150 (2015), 17–22.
4. Singh, K.E., Taylor, T.H., Pan, C.G., Stamos, M.J., Zell, J.A., Colorectal cancer incidence among young adults in California. J Adolesc Young Adult Oncol 3 (2014), 176–184.
5. Atkin, W.S., Cuzick, J., Northover, J.M., Whynes, D.K., Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 341 (1993), 736–740.
6. Fairley, T.L., Cardinez, C.J., Martin, J., et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer 107 (2006), 1153–1161.
7. Siegel, R.L., Jemal, A., Ward, E.M., Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 18 (2009), 1695–1698.
8. O'Connell, J.B., Maggard, M.A., Liu, J.H., Etzioni, D.A., Livingston, E.H., Ko, C.Y., Rates of colon and rectal cancers are increasing in young adults. Am Surg 69 (2003), 866–872.
9. O'Connell, J.B., Maggard, M.A., Livingston, E.H., Yo, C.K., Colorectal cancer in the young. Am J Surg 187 (2004), 343–348.
10. Bleyer, A., Barr, R., Hayes-Lattin, B., et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8 (2008), 288–298.
11. Theis, B., Nishri, D., Bahl, S., Ugnat, A.-M., Marrett, L., Cancer in young adults in Canada. 2006, Cancer Care Ontario Available at: http://www.cancercare.on.ca/ Accessed: April 10, 2017.
12. McLean, J., Rho, Y.S., Kuruba, G., et al. Clinical practice patterns in chemotherapeutic treatment regimens for metastatic colorectal cancer. Clin Colorectal Cancer 15 (2016), 135–140.
13. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
14. Ferrari, A., Bleyer, A., Participation of adolescents with cancer in clinical trials. Cancer Treat Rev 33 (2007), 603–608.
15. A Snapshot of Adolescent and Young Adult Cancers. Available at: http://www.cancer.gov/research/progress/snapshots/adolescent-young-adult-footnote3 Accessed: May 1, 2016.
16. Hubbard, J.M., Grothey, A., Adolescent and young adult colorectal cancer. J Natl Compr Canc Netw 11 (2013), 1219–1225.
17. Aaltonen, L.A., Salovaara, R., Kristo, P., et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338 (1998), 1481–1487.
18. Giraldez, M.D., Balaguer, F., Bujanda, L., et al. MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res 16 (2010), 5402–5413.
19. Limburg, P.J., Harmsen, W.S., Chen, H.H., et al. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol 9 (2011), 497–502.
20. Davis, D.M., Marcet, J.E., Frattini, J.C., Prather, A.D., Mateka, J.J., Nfonsam, V.N., Is it time to lower the recommended screening age for colorectal cancer?. J Am Coll Surg 213 (2011), 352–361.
21. Engstrom, P.F., Arnoletti, J.P., Benson, A.B. III, et al. NCCN clinical practice guidelines in oncology: colon cancer. J Natl Compr Canc Netw 7 (2009), 778–831.
22. Tan, C., Du, X., KRAS mutation testing in metastatic colorectal cancer. World J Gastroenterol 18 (2012), 5171–5180.
23. Toh, J.W., de Souza, P., Lim, S.H., et al. The potential value of immunotherapy in colorectal cancers: review of the evidence for programmed death-1 inhibitor therapy. Clin Colorectal Cancer 15 (2016), 285–291.
24. Wang, M.J., Ping, J., Li, Y., et al. The prognostic factors and multiple biomarkers in young patients with colorectal cancer. Sci Rep, 5, 2015, 10645.
25. Guastadisegni, C., Colafranceschi, M., Ottini, L., Dogliotti, E., Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur J Cancer 46 (2010), 2788–2798.
26. Abdelsattar, Z.M., Wong, S.L., Regenbogen, S.E., Jomaa, D.M., Hardiman, K.M., Hendren, S., Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer 122 (2016), 929–934.
27. Hu, C.Y., Bailey, C.E., You, Y.N., et al. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg 150 (2015), 245–251.
28. Kneuertz, P., Chang, G., Hu, C.Y., et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg 150 (2015), 402–409.
29. Vatandoust, S., Price, T.J., Ullah, S., et al. Metastatic colorectal cancer in young adults: a study from the South Australian population-based registry. Clin Colorectal Cancer 15 (2016), 32–36.
30. Taylor, M.C., Pounder, D., Ali-Ridha, N.H., Bodurtha, A., MacMullin, E.C., Prognostic factors in colorectal carcinoma of young adults. Can J Surg 31 (1988), 150–153.
31. Marble, K., Banerjee, S., Greenwald, L., Colorectal carcinoma in young patients. J Surg Oncol 51 (1992), 179–182.
32. Cusack, J.C., Giacco, G.G., Cleary, K., et al. Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. J Am Coll Surg 183 (1996), 105–112.
33. Adloff, M., Arnaud, J.P., Schloegel, M., Thibaud, D., Bergamaschi, R., Colorectal cancer in patients under 40 years of age. Dis Colon Rectum 29 (1986), 322–325.
34. Beckman, E.N., Gathright, J.B., Ray, J.E., A potentially brighter prognosis for colon carcinoma in the third and fourth decades. Cancer 54 (1984), 1478–1481.
35. Heys, S.D., Sherif, A., Bagley, J.S., Brittenden, J., Smart, C., Eremin, O., Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg 81 (1994), 685–688.
36. Lee, P.Y., Fletcher, W.S., Sullivan, E.S., Vetto, J.T., Colorectal cancer in young patients: characteristics and outcome. Am Surg 60 (1994), 607–612.
37. Forbes, S.S., Sutradhar, R., Paszat, L.F., Rabeneck, L., Urbach, D.R., Baxter, N.N., Long-term survival in young adults with colorectal cancer: a population-based study. Dis Colon Rectum 53 (2010), 973–978.
38. Mork, M.E., You, Y.N., Ying, J., et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J Clin Oncol 33 (2015), 3544–3549.
39. Friedrich, T., Leong, S., Lieu, C.H., Beyond RAS and BRAF: a target rich disease that is ripe for picking. J Gastrointest Oncol 7 (2016), 705–712.